Cite
MLA Citation
J. Rosenstock et al.. “Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial.” Diabetes, obesity & metabolism, vol. 17, no. 10, n.d., pp. 936–948. http://access.bl.uk/ark:/81055/vdc_100026577088.0x00000d